| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |